Lavo Life Sciences
Private Company
Biotechnology Research
San Francisco, California
2-10 employees
Founded 2022
About Lavo Life Sciences
Lavo Life Sciences provides AI-accelerated crystal structure prediction to revolutionize pharmaceutical development. The company offers the 'Crystal Console,' a web-based software platform, and dedicated contract research services for small molecule drugs. These solutions target pharmaceutical and biotech R&D teams to accelerate drug discovery, improve stability, and reduce development timelines.
Company Classification
Customer Types
B2B
Business Models
SubscriptionServices
Product & Service Types
AI-powered crystallography software platformContract research services for drug discovery
Funding
Total Funding
$500.0K
No. of Funding Rounds
2
Sign up to Ethos to access the full customer list, plus detailed competitor and product analysis.
Sign up to Ethos